OVERALL, IN VITRO DIAGNOSTICS (IVD) COMPANIES REPORTED A MIXED BAG of financial results for the quarter ending Dec. 31, 2024, with Becton, Dickinson and Company, Abbott Laboratories, and Siemens Healthineers showing the most momentum based on recent earnings. Generally, IVD manufacturers did not experience double-digit growth or drops year over year, indicating that some stability […]
Global IVD Companies Issue Fourth Quarter 2024 Earnings
IVD Companies Grow Revenue in Q4 and 2024 Amid Changing Market Forces
- By Robert Michel
- > From the Volume XXXII, No. 5 - March 31, 2025 Issue
- Tags: Abbott Laboratories, Babson, BD, Beckman Coulter, Becton Dickinson, Benjamin Lilienfeld, BetterWay, Bio-Rad Laboratories, Biopharma, Brian Blaser, Cepheid, cobas Mass Spectrometry, core lab, Danaher, digital pathology, G2 Intelligence, GT450, Hologic, hospital-based diagnostics, in vitro diagnostics, informatics, IVD, ivd/lab informatics, leica biosystems, life sciences, Marc Casper, MiniDraw Capillary Blood Collection System, molecular lab, pathology lab, Qiagen, QIAstat-Dx, QuidelOrtho, Rainer Blair, rapid diagnostics, Roche Group, Serum Work Area System, Siemens Healthineers, slide scanner, Stilla Technologies, syndromic testing system, sysmex, tariff, the dark report, Thermo Fisher Scientific, Tom Polon, VBP, volume-based procurement
